Trichostatin a protects liver against septic injury through inhibiting toll-like receptor signaling

Biomolecules and Therapeutics

Volumn 24, Issue 4, 2016, Pages 387-394

  Kim, So Jin ^a   Park, Jin Sook ^a   Lee, Do Won ^a   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Histone deacetylase inhibitor; Nuclear factor kappa b; Sepsis; Toll like receptor; Trichostatin a

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOPRECIPITATION; LIVER INJURY; LIVER PROTECTION; MALE; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE INJURY; WESTERN BLOTTING;

EID: 84977521113     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2015.176     Document Type: Article

References (36)

1. Abraham, E. (2003) Nuclear factor-kB and its role in sepsis-associated organ failure. J. Infect. Dis. 187 Suppl 2, S364-S369.
2. Baldwin, A. S. Jr. (1996) The NF-kB and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
3. Beg, A. A., Finco, T. S., Nantermet, P. V. and Baldwin, A. S. Jr. (1993) Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkBa: a mechanism for NF-kB activation. Mol. Cell. Biol. 13, 3301-3310.
4. Bergt, S., Wagner, N. M., Heidrich, M., Butschkau, A., Noldge-Schomburg, G. E., Vollmar, B. and Roesner, J. P. (2013) Hydrocortisone reduces the beneficial effects of toll-like receptor 2 deficiency on survival in a mouse model of polymicrobial sepsis. Shock 40, 414-419.
5. Bone, R. C. (1991) The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469.
6. Chakravortty, D., Koide, N., Kato, Y., Sugiyama, T., Mu, M. M., Yoshida, T. and Yokochi, T. (2000) The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264. 7 murine macrophage cells. J. Endotoxin Res. 6, 243-247.
7. Chaudry, I. H., Wichterman, K. A. and Baue, A. E. (1979) Effect of sepsis on tissue adenine nucleotide levels. Surgery 85, 205-211.
8. Chen, L. F., Mu, Y. and Greene, W. C. (2002) Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kB. EMBO J. 21, 6539-6548.
9. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J. and Tan, T. H. (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and g radiation. J. Biol. Chem. 271, 31929-31936.
10. Choi, J. H., Oh, S. W., Kang, M. S., Kwon, H. J., Oh, G. T. and Kim, D. Y. (2005) Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35, 89-96.
11. Ehrentraut, S., Lohner, R., Schwederski, M., Ehrentraut, H., Boehm, O., Noga, S., Langhoff, P., Baumgarten, G., Meyer, R. and Knuefermann, P. (2011) In vivo Toll-like receptor 4 antagonism restores cardiac function during endotoxemia. Shock 36, 613-620.
12. Finkelstein, R. A., Li, Y., Liu, B., Shuja, F., Fukudome, E., Velmahos, G. C., deMoya M. and Alam, H. B. (2010) Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock. J. Surg. Res. 163, 146-154.
13. Hebert, P. C., Drummond, A. J., Singer, J., Bernard, G. R. and Russell, J. A. (1993) A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104, 230-235.
14. Johnstone, R. W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1, 287-299.
15. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. and Akira, S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122.
16. Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y., Kim, C. W. and Kim, K. W. (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7, 437-443.
17. Lagu, T., Rothberg, M. B., Shieh, M. S., Pekow, P. S., Steingrub, J. S. and Lindenauer, P. K. (2012) Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit. Care Med. 40, 754-761.
18. Li, Y. and Alam, H. B. (2011) Modulation of acetylation: creating a prosurvival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock. J. Biomed. Biotechnol. 2011, 523481.
19. Lührs, H., Gerke, T., Schauber, J., Dusel, G., Melcher, R., Scheppach, W. and Menzel, T. (2001) Cytokine-activated degradation of inhibitory kB protein a is inhibited by the short-chain fatty acid butyrate. Int. J. Colorectal Dis. 16, 195-201.
20. Mittal, R., Peak-Chew, S. Y. and McMahon, H. T. (2006) Acetylation of MEK2 and IkB kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. U. S. A. 103, 18574-18579.
21. Nasu, Y., Nishida, K., Miyazawa, S., Komiyama, T., Kadota, Y., Abe, N., Yoshida, A., Hirohata, S., Ohtsuka, A. and Ozaki, T. (2008) Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthr. Cartil. 16, 723-732.
22. Nesseler, N., Launey, Y., Aninat, C., Morel, F., Mallédant, Y. and Seguin, P. (2012) Clinical review: The liver in sepsis. Crit. Care 16, 235.
23. Pan, L. N., Lu, J. and Huang, B. (2007) HDAC inhibitors: a potential new category of anti-tumor agents. Cell. Mol. Immunol. 4, 337-343.
24. Riedemann, N. C., Guo, R. F. and Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524.
25. Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A. L., Reymond, M. K., Miconnet, I., Schrenzel, J., François, P. and Calandra, T. (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117, 1205-1217.
26. Sha, T., Iizawa, Y. and Ii, M. (2011) Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis. Shock 35, 205-209.
27. Singhal, S., Alulen, M. W., McAnnally, J. R., Smith, K. S., Donnelly, J. P. and Wang, H. E. (2013) National estimates of emergency department visits for pediatric severe sepsis in the United States. PeerJ 1, e79.
28. Takala, A., Nupponen, I., Kylänpää-Bäck, M. L. and Repo, H. (2002) Markers of inflammation in sepsis. Ann. Med. 34, 614-623.
29. Takashima, K., Matsunaga, N., Yoshimatsu, M., Hazeki, K., Kaisho, T., Uekata, M., Hazeki, O., Akira, S., Iizawa, Y. and Ii M. (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157, 1250-1262.
30. Tong, X., Yin, L. and Giardina, C. (2004) Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem. Biophys. Res. Commun. 317, 463-471.
31. Toscano, M. G., Ganea, D. and Gamero, A. M. (2011) Cecal ligation puncture procedure. J. Vis. Exp. 2860.
32. Williams, D. L., Ha, T., Li, C., Kalbfleisch, J. H., Schweitzer, J., Vogt, W. and Browder, I. W. (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31, 1808-1818.
33. Wu, J. and Grunstein, M. (2000) 25 years after the nucleosome model: chromatin modifications. Trends Biochem. Sci. 25, 619-623.
34. Zhang, L., Jin, S., Wang, C., Jiang, R. and Wan, J. (2010) Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World J. Surg. 34, 1676-1683.
35. Zhang, L., Wan, J., Jiang, R., Wang, W., Deng, H., Shen, Y., Zheng, W. and Wang, Y. (2009) Protective effects of trichostatin A on liver injury in septic mice. Hepatol. Res. 39, 931-938.
36. Zhao, T., Li, Y., Liu, B., Liu, Z., Chong, W., Duan, X., Deperalta, D. K., Velmahos, G. C. and Alam, H. B. (2013) Novel pharmacologic treatment attenuates septic shock and improves long-term survival. Surgery 154, 206-213.